Better CNS clinical development

Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Enabled by a Curated Network of Solutions, connected via one platform. 
Get in touch
Why clouds of care

We de-risk your clinical development with multimodal insights

De-risk your clinical development with multimodal insights. By acquiring, aggregating, and analyzing multimodal data from best-matched Digital Health Tech (DHT) solutions, we identify clinically relevant, scientifically validated, commercially viable, and regulatory-accepted endpoints within your specific context of use.

Clinical outcome

The shared neurobiology of different disorders leads to shared clinical outcomes across different indications.

Clinical endpoints

To measure clinical outcomes within a specific context of use, we need to identify hypothesis-driven and future-proof endpoints.

Multimodal

By selecting the appropriate modalities and matching the right DHTs from our Curated Network of Solutions, we enable the adoption of meaningful endpoints.

our services

Our multimodal approach to unearthing meaningful insights in CNS

Starting from electrophysiology, improving ROI in the process, we help gather insights in CNS. Enabled by our vendor-neutral, data-driven services through our CNS platform.

Multimodal endpoints advisory

Match modalities with meaningful endpoints within your context of use.​

Digital Health Technology partner selection​

Select the appropriate DHT partners from our Curated Network of Solutions.​

Data acquisition, aggregation & analysis​

Acquire, aggregate, and analyze multimodal data on our CNS platform.​

Discover our CNS platform

Meaningful insights & endpoint validation

Discover novel and validate existing CNS endpoints through multimodal insights.

Interpretation & result reporting​

Translate data insights into an actionable clinical development strategy.

Learn more about the full service​
clouds of caRe in numbers

From scientist to scientist, for patients

A dynamic team of scientists, clinicians, engineers and​ software developers backed by expert advisors.​

0
+

Patients impacted

0
+

EEGs & PSGs analyzed

0

Clinical trials enriched

0
+

Papers published

0

Academic and clinical sites

0

Clinicians​onboarded​

0

Expert central readers

About us
View publications
Case studies

How we successfully helped others in the industry

Standardized Pharmaco-EEG in Clinical Development

Neurology

Pharmaco-EEG measures the direct and indirect effects of active compounds on brain activity to evaluate a drug's pharmacodynamic (PD) and pharmacokinetic (PK) properties, its CNS penetration, and its potential therapeutic or toxic effects. By employing standardized methodologies, pharmaco-EEG can serve as a translational biomarker, bridging preclinical research and clinical drug development and aiding in the evaluation of CNS-active compounds in humans.‍

Read full case study
View our case studies

Already trusted by

Biohaven
ECET
GRIN Therapeutics
Ionis
Longboard Pharmaceuticals
Neurocrine
UCB

Let’s discuss how​ we can boost your clinical development. ​

Get in touch